Biote earnings were $15.6M for the trailing 12 months ending Mar 31, 2026, with -27.9% growth year over year. The latest BTMD earnings report on Mar 31, 2026 announced Q1 2026 earnings of $2.3M, up 16.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BTMD reported annual earnings of $27.0M, with 756.7% growth.
BTMD past earnings growth
How has BTMD's earnings growth performed historically?
On BTMD's earnings call on Invalid Date, Biote (NASDAQ: BTMD) reported Q1 2026 earnings per share (EPS) of $0.07, up 84.09% year over year. Total BTMD earnings for the quarter were $2.28 million. In the same quarter last year, Biote's earnings per share (EPS) was $0.44.
As of the last Biote earnings report, Biote is currently profitable. Biote's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $15.60 million, a 25.82% decrease year over year.
What was BTMD's earnings growth in the past year?
As of Biote's earnings date in Invalid Date, Biote's earnings has grown -27.94% year over year. This is 92.22 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 64.27%. BTMD earnings in the past year totalled $15.60 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.